Fewer Complications at 18 Months Seen With Post-COVID-19 Vaccination Myocarditis
In contrast, post-COVID-19 myocarditis shows outcomes similar to conventional myocarditis
People With Chronic Liver Disease Face More Barriers to Health Care
Findings tied to higher prevalence of socioeconomic vulnerabilities compared with those with chronic obstructive pulmonary disease or cardiovascular disease
Automated Pipeline Can ID Clinically Significant Mitral Regurgitation
MR moderate or greater in severity and severe MR detected with high areas under the curve
Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart Failure
MACE, heart failure composite end point, cardiovascular death, and all-cause death all improved with semaglutide for patients with versus without heart failure
Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price
Team-Based Documentation Can Increase Visit Volume, Cut Documentation Time
High-intensity adopters had reduction in documentation for full postadoption periods and following learning period
Radiotherapy Dose to Cardiac Substructures Linked to Arrhythmias
After adjustment for baseline cardiovascular risk, pulmonary vein volume receiving 5 Gy linked to atrial fibrillation
After Weighting, 3.6 Million Likely to Be Newly Eligible for Semaglutide
If all newly eligible beneficiaries receive semaglutide, maximum Medicare spending could be $34 to $145 billion annually
Awareness of Unruptured Aneurysm Diagnosis Increases Risk for Mental Illness
Incidence rate of mental illness higher among those with UIA, especially in younger age groups
Prevalence of HTN Increases With Neighborhood Disadvantage
Higher hypertension rate and lower treatment rate seen for highest versus lowest ADI quintile neighborhood
